Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study

Table 3 Adjusted^a hazards ratios and 95% confidence intervals for the predictors of cardiovascular disease

Predictor variable	Men (n = 485)		Women (n = 492)
Predictor variable	HR (95% CI)	P-value	HR (95% CI)	P-value
Sociodemographic variables
Age per 10 years	1.50 (1.19–1.89)	0.001	1.10 (0.77–1.56)	0.597
History of smoking	1.80 (1.07–3.02)	0.027	0.00 (0.00–3.07)	0.967
Treatment modalities
Antidiabetic drugs	0.87 (0.41–1.82)	0.706	1.67 (0.67–4.15)	0.274
Antihypertensive agents	0.84 (0.42–1.68)	0.621	0.73 (0.28–1.93)	0.530
Lipid-lowering medication	0.81 (0.44–1.49)	0.497	1.04 (0.42–2.58)	0.935
Anthropometric parameters
BMI (kg/m²)	1.00 (0.96–1.05)	0.982	0.96 (0.92–1.02)	0.175
SBP per 10 mmHg	1.20 (1.01–1.44)	0.042	1.58 (1.27–1.96)	< 0.001
DBP per 10 mmHg	1.00 (0.77–1.31)	0.998	0.71 (0.50–1.01)	0.056
Laboratory parameters
TC/HDL-C ratio	0.95 (0.77–1.17)	0.613	1.44 (1.02–2.04)	0.037
LDL-C (mmol/L)	1.10 (0.83–1.44)	0.516	0.80 (0.50–1.30)	0.365
eGFR (mL/min.1.73 m²)	0.98 (0.97–0.99)	< 0.001	0.98 (0.97–1.00)	0.043
HbA1c (%)	1.16 (1.02–1.32)	0.029	1.24 (1.03–1.49)	0.022

BMI body mass index, eGFR estimated glomerular filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, HbA1c glycosylated hemoglobin A1c, HR hazards ratio, CI confidence interval
^aMultivariable Cox model adjusted for all of the predictors in the final model

ISSN: 1471-2261